Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Nissen

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Hepatology Communications|April 27, 2026
Liver transplantation is the major determinant of ≥10-year survival in patients with hepatocellular carcinomaMohammad Saeid Rezaee-Zavareh, Joseph C Ahn, Hyunseok Kim, et al.
Liver Cancer|October 9, 2025
Curative Treatment after Immunotherapy Leads to Excellent Outcomes in Patients with Hepatocellular CarcinomaGwang Hyeon Choi, Hyun-Seok Kim, Michael Luu, et al.
Hepatology Communications|June 19, 2024
Development and validation of a biomarker index for HCC treatment responseJeff Liang, Po-Yi Li, Joshua Norman, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Hepatology Communications|April 27, 2026
Liver transplantation is the major determinant of ≥10-year survival in patients with hepatocellular carcinomaMohammad Saeid Rezaee-Zavareh, Joseph C Ahn, Hyunseok Kim, et al.
Liver Cancer|October 9, 2025
Curative Treatment after Immunotherapy Leads to Excellent Outcomes in Patients with Hepatocellular CarcinomaGwang Hyeon Choi, Hyun-Seok Kim, Michael Luu, et al.
Hepatology Communications|June 19, 2024
Development and validation of a biomarker index for HCC treatment responseJeff Liang, Po-Yi Li, Joshua Norman, et al.
Pageof 7